AR052048A1 - Composiciones farmaceuticas para el tratamiento de la celulitis - Google Patents
Composiciones farmaceuticas para el tratamiento de la celulitisInfo
- Publication number
- AR052048A1 AR052048A1 ARP050105224A ARP050105224A AR052048A1 AR 052048 A1 AR052048 A1 AR 052048A1 AR P050105224 A ARP050105224 A AR P050105224A AR P050105224 A ARP050105224 A AR P050105224A AR 052048 A1 AR052048 A1 AR 052048A1
- Authority
- AR
- Argentina
- Prior art keywords
- cellulite
- treatment
- pharmaceutical compositions
- mesotherapy
- contain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/06—Preparations for care of the skin for countering cellulitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Birds (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Composiciones farmacéutica para administracion topica o para el uso en mesoterapia que contienen un inhibidor de la PDE3 como principio activo, y su uso en el tratamiento de la celulitis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI20042371 ITMI20042371A1 (it) | 2004-12-14 | 2004-12-14 | Composizioni farmaceutiche topiche per il trattamento della cellulite |
ITMI20051739 ITMI20051739A1 (it) | 2005-09-20 | 2005-09-20 | Composizioni farmaceutiche topiche per il trattamento della cellulite |
Publications (1)
Publication Number | Publication Date |
---|---|
AR052048A1 true AR052048A1 (es) | 2007-02-28 |
Family
ID=35708888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP050105224A AR052048A1 (es) | 2004-12-14 | 2005-12-13 | Composiciones farmaceuticas para el tratamiento de la celulitis |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100016324A1 (es) |
EP (1) | EP1824463A1 (es) |
JP (1) | JP2008523127A (es) |
KR (1) | KR20070086101A (es) |
AR (1) | AR052048A1 (es) |
AU (1) | AU2005315919B2 (es) |
BR (1) | BRPI0518554A2 (es) |
CA (1) | CA2590288A1 (es) |
HK (1) | HK1111599A1 (es) |
IL (1) | IL183893A0 (es) |
MA (1) | MA29145B1 (es) |
MX (1) | MX2007007015A (es) |
NO (1) | NO20073575L (es) |
NZ (1) | NZ555836A (es) |
PE (1) | PE20060746A1 (es) |
RU (1) | RU2401098C2 (es) |
TN (1) | TNSN07203A1 (es) |
WO (1) | WO2006063714A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100963268B1 (ko) | 2006-11-22 | 2010-06-11 | 에스케이케미칼주식회사 | 실로스타졸과 은행잎 추출물을 함유한 약제 조성물 |
ITMI20070604A1 (it) | 2007-03-26 | 2008-09-27 | Menarini Farma Ind | Preparazioni cosmetiche per la riduzione degli inestetismi della cellulite |
MX337850B (es) * | 2009-03-02 | 2016-03-23 | Doris Hexsel | Lipoatrofia cosmetica medicinal. |
MY170724A (en) | 2012-01-27 | 2019-08-27 | Biotropics Malaysia Berhad | Use of certain trioxygenated benzene derivatives in body fat management |
CN104161756B (zh) * | 2014-06-13 | 2017-02-01 | 河北智同医药控股集团有限公司 | 一种盐酸奥普力农注射液组合物 |
EA031658B1 (ru) * | 2017-06-30 | 2019-02-28 | Акционерное Общество "Верофарм" | Антицеллюлитный косметический комплекс |
RU2694898C1 (ru) * | 2018-08-29 | 2019-07-18 | Талагаева Елена Владимировна | Крем для лица и тела |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4147497A (en) | 1977-01-04 | 1979-04-03 | Gte Sylvania Incorporated | Hand-operable signal device using percussively-ignitable flashlamps |
IT1270602B (it) | 1994-07-12 | 1997-05-07 | Indena Spa | Formulazioni a base di esculoside e loro uso in campo farmaceutico e cosmetico |
JP3452986B2 (ja) * | 1994-09-13 | 2003-10-06 | 花王株式会社 | 脂肪分解促進剤 |
JP4182183B2 (ja) | 1999-08-24 | 2008-11-19 | ディーエスエム アイピー アセッツ ビー.ブイ. | 痩身用皮膚化粧料 |
FR2802811B1 (fr) * | 1999-12-24 | 2002-02-15 | Silab Sa | Procede d'extraction d'un principe actif a partir de petales de bigarade, notamment pour le traitement de la cellulite, principe actif obtenu, compositions cosmetiques et traitements adaptes |
WO2001060331A2 (en) * | 2000-02-15 | 2001-08-23 | Zen-Bio, Inc. | Compositions for preventing cellulite in mammalian skin |
DE10009423A1 (de) | 2000-02-28 | 2001-09-06 | Henkel Kgaa | Kosmetische und pharmazeutische Zubereitungen |
DE10009424A1 (de) | 2000-02-28 | 2001-09-06 | Henkel Kgaa | Verwendung von Flavonen oder Isoflavonen zur Cellulite-Behandlung |
ITMI20011182A1 (it) * | 2001-06-05 | 2002-12-05 | Indena Spa | Composizioni farmaceutiche e/o cosmetiche per il trattamento di adiposita' localizzate e della cellulite |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
-
2005
- 2005-12-06 JP JP2007545893A patent/JP2008523127A/ja active Pending
- 2005-12-06 KR KR1020077013256A patent/KR20070086101A/ko not_active Application Discontinuation
- 2005-12-06 NZ NZ555836A patent/NZ555836A/en not_active IP Right Cessation
- 2005-12-06 AU AU2005315919A patent/AU2005315919B2/en not_active Ceased
- 2005-12-06 WO PCT/EP2005/013041 patent/WO2006063714A1/en active Application Filing
- 2005-12-06 MX MX2007007015A patent/MX2007007015A/es unknown
- 2005-12-06 CA CA002590288A patent/CA2590288A1/en not_active Abandoned
- 2005-12-06 EP EP05816249A patent/EP1824463A1/en not_active Withdrawn
- 2005-12-06 RU RU2007120465/15A patent/RU2401098C2/ru not_active IP Right Cessation
- 2005-12-06 BR BRPI0518554-8A patent/BRPI0518554A2/pt not_active IP Right Cessation
- 2005-12-13 AR ARP050105224A patent/AR052048A1/es not_active Application Discontinuation
- 2005-12-13 PE PE2005001440A patent/PE20060746A1/es not_active Application Discontinuation
-
2007
- 2007-05-22 TN TNP2007000203A patent/TNSN07203A1/fr unknown
- 2007-06-13 IL IL183893A patent/IL183893A0/en unknown
- 2007-07-10 NO NO20073575A patent/NO20073575L/no not_active Application Discontinuation
- 2007-07-12 MA MA30067A patent/MA29145B1/fr unknown
-
2008
- 2008-03-04 HK HK08102411.9A patent/HK1111599A1/xx not_active IP Right Cessation
-
2009
- 2009-09-25 US US12/567,045 patent/US20100016324A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PE20060746A1 (es) | 2006-09-06 |
TNSN07203A1 (en) | 2008-11-21 |
KR20070086101A (ko) | 2007-08-27 |
RU2007120465A (ru) | 2009-01-27 |
BRPI0518554A2 (pt) | 2008-11-25 |
US20100016324A1 (en) | 2010-01-21 |
JP2008523127A (ja) | 2008-07-03 |
MX2007007015A (es) | 2007-07-04 |
IL183893A0 (en) | 2007-10-31 |
CA2590288A1 (en) | 2006-06-22 |
AU2005315919A1 (en) | 2006-06-22 |
EP1824463A1 (en) | 2007-08-29 |
RU2401098C2 (ru) | 2010-10-10 |
WO2006063714A1 (en) | 2006-06-22 |
MA29145B1 (fr) | 2008-01-02 |
NZ555836A (en) | 2009-09-25 |
HK1111599A1 (en) | 2008-08-15 |
AU2005315919B2 (en) | 2011-06-09 |
NO20073575L (no) | 2007-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
CL2008000442A1 (es) | Composicion farmaceutica que comprende a un quitosano, un ingrediente activo cosmetico o farmaceutico, y un solvente volatil; y su uso para tratar psoriasis, micosis entre otras enfermedades. | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
WO2012160180A3 (en) | Pharmaceutical composition for administration to nails | |
CL2012003281A1 (es) | Uso de compuestos específicos estimuladores y/o activadores de sgc; formulacion farmaceutica que comprende dichos compuestos; kit que comprende los compuestos, y uso para la prevencion y/o tratamiento de la esclerosis sistematica. | |
ECSP067076A (es) | Derivados de pirimidina urea como inhibidores de la quinasa | |
AR054227A1 (es) | Composicion de principios activos | |
CO6761350A2 (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogenesis | |
ECSP13012546A (es) | Formulación tópica para un inhibidor de jak | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
CL2007002095A1 (es) | Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado. | |
CL2007003523A1 (es) | Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer | |
AR052048A1 (es) | Composiciones farmaceuticas para el tratamiento de la celulitis | |
PA8720801A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento de la depresion | |
UY31456A1 (es) | Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos | |
CL2007003557A1 (es) | Compuestos derivados de heterociclos de nitrogeno, inhibidores de la actividad sobre b-raf; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer. | |
AR072685A1 (es) | Composicion topica para el tratamiento de queratosis actinica | |
CL2011003327A1 (es) | Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales. | |
BRPI0909296A2 (pt) | uso de pelo menos um princípio ativo, e, composições cosmética, farmacêutica e/ou dermatológica | |
CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
DK1893237T3 (da) | Farmaceutisk sammensætning, der omfatter en organopolysiloxan ela-stomer og et solubiliseret aktivt stof | |
CL2009001841A1 (es) | Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto. | |
CL2008002758A1 (es) | Composicion que comprende al menos un principio activo laxante y al menos un principio activo antiespumante; uso para el tratamiento del estrenimiento. | |
UY29561A1 (es) | Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |